CPHI Korea Trip: Client Visits Deepen Cooperation, Factory Tours Foster Joint Development

Recently, the Biocom team traveled to Seoul, South Korea, to participate in CPHI Korea 2025, the World Pharmaceutical Ingredients Exhibition. During the event, the team engaged with global pharmaceutical industry leaders to explore collaborative opportunities. This trip provided an in-depth look into South Korea’s pharmaceutical ecosystem through on-site visits and face-to-face communication, strengthening partnerships with global allies and injecting new energy into expanding Biocom’s presence in the Asian market while promoting pharmaceutical cooperation under the "Belt and Road" initiative.

Throughout the exhibition, the team held extensive discussions with clients from South Korea and the broader Asia-Pacific region. They gained detailed insights into customer needs and introduced Biocom’s competitive portfolio of APIs and formulations, including Amenamevir, Azilsartan Medoxomil Potassium, and Vonoprazan Fumarate. Both parties reached a strong consensus on key issues such as product quality, supply chain stability, and market potential, with several cooperative intentions preliminary established.

Another highlight of the trip was the on-site visits to multiple long-term partner factories. By touring production facilities, the team gained comprehensive understanding of partners’ manufacturing processes, quality control systems, and R&D capabilities. In return, Biocom showcased its own strengths in R&D, production, and regulatory compliance. These mutual visits not only enhanced trust but also laid a solid foundation for deeper technical collaboration and supply chain integration.

Although the exhibition has concluded, cooperation continues. Biocom sincerely thanks all clients, factory partners, and industry colleagues who supported this visit to South Korea! We look forward to working hand in hand to open a new chapter in Sino-Korean pharmaceutical collaboration and contribute "Chinese expertise" to the high-quality development of the global pharmaceutical industry!